BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36736872)

  • 1. Evaluation of β-lapachone-methyl-β-cyclodextrin inclusion complex prepared by spray drying and its application against different developmental stages of Schistosoma mansoni in murine model.
    Soares RN; Ximenes ECPA; Araújo SB; Silva RLD; Souza VMO; Coelho LCBB; Neto JLF; Neto PJR; Araújo HDA; Aires AL; Albuquerque MCPA
    Chem Biol Interact; 2023 Mar; 373():110374. PubMed ID: 36736872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Lapachone: a naphthoquinone with promising antischistosomal properties in mice.
    Aires Ade L; Ximenes EC; Barbosa VX; Góes AJ; Souza VM; Albuquerque MC
    Phytomedicine; 2014 Feb; 21(3):261-7. PubMed ID: 24090700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of cnicin from blessed thistle (Centaurea benedicta) and its inclusion complexes with cyclodextrins against Schistosoma mansoni.
    Queiroz LS; Ferreira EA; Mengarda AC; Almeida ADC; Pinto PF; Coimbra ES; de Moraes J; Denadai ÂML; Da Silva Filho AA
    Parasitol Res; 2021 Apr; 120(4):1321-1333. PubMed ID: 33164156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
    Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI
    Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes.
    Nasongkla N; Wiedmann AF; Bruening A; Beman M; Ray D; Bornmann WG; Boothman DA; Gao J
    Pharm Res; 2003 Oct; 20(10):1626-33. PubMed ID: 14620518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological and immunological evaluation of different regimens of praziquantel treatment in a mouse model of Schistosoma mansoni infection.
    Membe Femoe U; Boukeng Jatsa H; Greigert V; Brunet J; Cannet C; Kenfack MC; Gipwe Feussom N; Kadji Fassi JB; Tienga Nkondo E; Abou-Bacar A; Pfaff AW; Dimo T; Kamtchouing P; Tchuem Tchuenté LA
    PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010382. PubMed ID: 35446855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
    de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
    Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The encapsulation of β-lapachone in 2-hydroxypropyl-β-cyclodextrin inclusion complex into liposomes: a physicochemical evaluation and molecular modeling approach.
    Cavalcanti IM; Mendonça EA; Lira MC; Honrato SB; Camara CA; Amorim RV; Mendes Filho J; Rabello MM; Hernandes MZ; Ayala AP; Santos-Magalhães NS
    Eur J Pharm Sci; 2011 Oct; 44(3):332-40. PubMed ID: 21888967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosomicidal and hepatoprotective activity of gamma-aminobutyric acid (GABA) alone or combined with praziquantel against Schistosoma mansoni infection in murine model.
    Fahmy AM; William S; Hegab A; Tm D
    Exp Parasitol; 2022 Jul; 238():108260. PubMed ID: 35447136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural analysis of β-lapachone-induced surface membrane damage in male adult Schistosoma mansoni BH strain worms.
    Aires Ade L; Ximenes EC; Silva RA; Barbosa VX; Góes AJ; Peixoto CA; Souza VM; Albuquerque MC
    Exp Parasitol; 2014 Jul; 142():83-90. PubMed ID: 24768955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.
    Ribeiro A; Figueiras A; Santos D; Veiga F
    AAPS PharmSciTech; 2008; 9(4):1102-9. PubMed ID: 18975116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered immunoglobulin isotype profile and anti-immature worm surface immunoglobulins in mice harboring a praziquantel-resistant Schistosoma mansoni isolate.
    Hanallah S; El-Lakkany N; Mahmoud S; Mousa M; Botros S
    APMIS; 2003 Dec; 111(12):1125-32. PubMed ID: 14678022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni.
    el-Lakkany NM; el-Din SH; Sabra AN; Hammam OA
    Mem Inst Oswaldo Cruz; 2011 Nov; 106(7):814-22. PubMed ID: 22124553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
    Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
    Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin growth factor inhibitor as a potential new anti-schistosoma drug: An in vivo experimental study.
    Elhenawy AA; Ashour RH; Nabih N; Shalaby NM; El-Karef AA; Abou-El-Wafa HS
    Biomed Pharmacother; 2017 Nov; 95():1346-1358. PubMed ID: 28946182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the mode of action of 1,2,6,7-tetraoxaspiro [7.11] nonadecane (N-89) against adult Schistosoma mansoni worms.
    Blay EA; Kumagai T; Yamabe M; Hino A; Shimogawara R; Kim HS; Sato A; Ichimura K; Ayi I; Iwanaga S; Ohta N
    Parasitol Int; 2018 Aug; 67(4):403-412. PubMed ID: 29617630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating beta-lapachone release from polymer millirods through cyclodextrin complexation.
    Wang F; Blanco E; Ai H; Boothman DA; Gao J
    J Pharm Sci; 2006 Oct; 95(10):2309-19. PubMed ID: 16883563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
    Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
    Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potent effect of silymarin combination with Praziquantel or mirazid for Schistosoma mansoni treatment in infected male swiss albino mice.
    El-Nagar DM; Al Olayan EM; Aloufi AS; Khatab AR
    Trop Biomed; 2021 Mar; 38(1):22-27. PubMed ID: 33797519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.